Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wen-Yu Chang

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
The Kaohsiung Journal of Medical Sciences|August 21, 2003
Alström syndrome with acute pancreatitis: a case reportWen-Chih Wu, Shinn-Cherng Chen, Chia-Yen Dia, et al.
Antiviral Research|September 29, 2004
The prevalence and clinical characteristics of coinfection of SENV-H among Taiwanese chronic hepatitis C patients with combination therapy of high-dose interferon-alfa and ribavirinChia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|December 20, 2024
Serial changes in metabolic dysfunction-associated steatotic liver disease after sleeve gastrectomy and their associations with abdominal adiposity: a prospective cohort studyChung-Yi Yang, Jian-Han Chen, Chung-Yen Chen, et al.
Journal of Hepatology|February 24, 2009
Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patientsChia-Yen Dai, Jee-Fu Huang, Ming-Yen Hsieh, et al.
Antiviral Research|July 2, 2003
Tumor necrosis factor alpha promoter polymorphisms at position -308 in Taiwanese chronic hepatitis C patients treated with interferon-alphaMing-Lung Yu, Chia-Yen Dai, Chao-Chin Chiu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 20, 2006
A randomized trial of 24- vs. 48-week courses of PEG interferon alpha-2b plus ribavirin for genotype-1b-infected chronic hepatitis C patients: a pilot study in TaiwanMing-Lung Yu, Chia-Yen Dai, Zu-Yau Lin, et al.
World Journal of Gastroenterology|July 15, 2005
Co-infection of SENV-D among chronic hepatitis C patients treated with combination therapy with high-dose interferon-alfa and ribavirinChia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, et al.
Antiviral Research|July 30, 2005
Polymorphisms in the interferon-gamma gene at position +874 in patients with chronic hepatitis C treated with high-dose interferon-alpha and ribavirinChia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, et al.
Japanese Journal of Infectious Diseases|February 24, 2006
Prevalence and clinical significance of HGV/GBV-C infection in patients with chronic hepatitis B or CJeng-Fu Yang, Chia-Yen Dai, Wan-Long Chuang, et al.
Journal of Gastroenterology and Hepatology|April 23, 2002
Incidence and clinical outcome of icteric type hepatocellular carcinomaJee-Fu Huang, Liang-Yen Wang, Zu-Yau Lin, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
The Kaohsiung Journal of Medical Sciences|August 21, 2003
Alström syndrome with acute pancreatitis: a case reportWen-Chih Wu, Shinn-Cherng Chen, Chia-Yen Dia, et al.
Antiviral Research|September 29, 2004
The prevalence and clinical characteristics of coinfection of SENV-H among Taiwanese chronic hepatitis C patients with combination therapy of high-dose interferon-alfa and ribavirinChia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|December 20, 2024
Serial changes in metabolic dysfunction-associated steatotic liver disease after sleeve gastrectomy and their associations with abdominal adiposity: a prospective cohort studyChung-Yi Yang, Jian-Han Chen, Chung-Yen Chen, et al.
Journal of Hepatology|February 24, 2009
Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patientsChia-Yen Dai, Jee-Fu Huang, Ming-Yen Hsieh, et al.
Antiviral Research|July 2, 2003
Tumor necrosis factor alpha promoter polymorphisms at position -308 in Taiwanese chronic hepatitis C patients treated with interferon-alphaMing-Lung Yu, Chia-Yen Dai, Chao-Chin Chiu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 20, 2006
A randomized trial of 24- vs. 48-week courses of PEG interferon alpha-2b plus ribavirin for genotype-1b-infected chronic hepatitis C patients: a pilot study in TaiwanMing-Lung Yu, Chia-Yen Dai, Zu-Yau Lin, et al.
World Journal of Gastroenterology|July 15, 2005
Co-infection of SENV-D among chronic hepatitis C patients treated with combination therapy with high-dose interferon-alfa and ribavirinChia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, et al.
Antiviral Research|July 30, 2005
Polymorphisms in the interferon-gamma gene at position +874 in patients with chronic hepatitis C treated with high-dose interferon-alpha and ribavirinChia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, et al.
Japanese Journal of Infectious Diseases|February 24, 2006
Prevalence and clinical significance of HGV/GBV-C infection in patients with chronic hepatitis B or CJeng-Fu Yang, Chia-Yen Dai, Wan-Long Chuang, et al.
Journal of Gastroenterology and Hepatology|April 23, 2002
Incidence and clinical outcome of icteric type hepatocellular carcinomaJee-Fu Huang, Liang-Yen Wang, Zu-Yau Lin, et al.
Pageof 9